3/23/2021Everest Med Files NDA for cIAI Drug Xerava (Eravacycline) in China

3/23/2021NMPA Revises Packages Insert of Systemic Quinolone Drugs

3/23/2021NMPA Revises Packages Insert of Mouse Nerve Growth Factor

3/23/2021NIFDC Issues the 2020 National Drug Sample Inspection Annual Report

3/23/2021Review of Chinese CDE-Accepted Drug Registration Applications in 2020

3/22/2021Bayer Launches Prostate Cancer Drugs Nubeqa and Xofigo in China

3/22/2021Sesen and Qilu Announce Chinese IND Approval for Vicineum

3/19/2021Recent Executive Moves

3/18/2021111, Inc. Enters Unique Strategic Partnership with BeiGene

3/18/2021WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC...

3/18/2021Complix Agrees with I-Mab to Develop Cell Penetrating Alphabodies aga...

3/18/2021SAMR Issues the Measures on Supervision and Administration of Online T...

3/18/2021NMPA Revises Packages Inserts of Haloperidol Formulations

3/18/2021NMPA Revises Packages Inserts of Sodium Ferulate for Injection

3/18/2021Ping An Good Doctor: Cross-Sectional Survey

3/17/2021Pfizer To Be Granted Priority Review for Its NDA of Abrocitinib

3/17/2021NHSA Releases Its 2020 Healthcare Security Sector Development Statisti...

3/17/2021Daewoong Pharma Signs $338M Deal Licensing Out Fexuprazan to Yangtze ...

3/16/2021AVEO Reclaims Full Global Rights to Antibody Drug from CANbridge

3/16/2021CDE Issues the Technical Requirements for Topical Dermatological Gener...

3/16/2021NHC Solicits Comments on the draft Provisions for Ethical Review of Li...

3/16/2021Snapshot of 11 Domestic Class 1 New Drugs Approved in China Last Year

3/16/2021Snapshot of Biological Product Registration and Launch in China Last Y...

3/16/2021Chinese Chemical Drug Manufacturing Industry Revenue Down Slightly in ...

3/16/2021Italfarmaco Group Agreed with Luye Pharma to Commercialize Rivastigmi...

3/16/2021Pfizer to Halt Biosimilar Production in China and Sell Its Hangzhou Bi...

3/16/2021Remegen Wins China Approval for Lupus Drug Telitacicept

3/16/2021BeiGene Announces Acceptance of a Supplemental Biologics License Appli...

3/16/2021Teva CEO Talks About Risks in Excessive Reliance on China for APIs

3/16/2021China Approves Another COVID-19 Vaccine for Emergency Use

Page:139/719 Total number of articles:21555: [First][<<] [137] [138] [139] [140] [141] [>>] [End]